About Navamedic
Navamedic is a company based in Lysaker (Norway) founded in 2004. Navamedic has completed 1 acquisition, including Impolin. Navamedic offers products and services including Eroxon, Medical Nutrition Products, and Antibiotics.
- Headquarter Lysaker, Norway
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Navamedic Asa
-
Annual Revenue
$46.81 M (USD)3.8as on Dec 31, 2024
-
Net Profit
-$483.56 K (USD)59.92as on Dec 31, 2024
-
EBITDA
$4.1 M (USD)31.11as on Dec 31, 2024
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Navamedic
Navamedic offers a comprehensive portfolio of products and services, including Eroxon, Medical Nutrition Products, and Antibiotics.
Clinically proven treatment for erectile dysfunction in men.
Specialized products for metabolic disorders like Phenylketonuria.
Medications for bacterial infections and related health needs.
People of Navamedic
Unlock access to complete
Funding Insights of Navamedic
Investors in Navamedic
Navamedic has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Reiten & Co.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Reiten & Co is engaged in private equity investments.
|
Locked | Locked | Locked |
Investor details for Navamedic
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Navamedic
Navamedic has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Impolin.
Investment portfolio details for Navamedic
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Diversified drugs are distributed by Impolin in Sweden.
|
Locked | Locked | 2004 | Locked |
Complete acquisition details for Navamedic
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Navamedic
Detailed financials for Navamedic
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Navamedic Comparisons
Peer comparison for Navamedic
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Navamedic
Detailed competitors of Navamedic
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Navamedic
Complete news archive for Navamedic
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Navamedic
Navamedic was founded in 2004 and raised its 1st funding round 14 years after it was founded.
Navamedic is headquartered in Lysaker, Norway.
Kathrine Gamborg Andreassen is the current CEO of Navamedic.
Annual revenue of Navamedic is $46.81M as on Dec 31, 2024.
Navamedic was founded in 2004 and is based in Lysaker, Norway. Operations focus on the manufacturing and marketing of pharmaceutical formulation products within the healthcare sector. Business areas encompass pharmaceuticals, nutrition products, and consumer care items. Product groups cover female care, medical nutrition, oral medicine, urology, dermatology, tenderhospital supplies, rheumatology, oncology, cardiology, antibiotics, immunology, neurology, gastrointestinal, and endocrinology treatments.
Navamedic offers Eroxon, Medical Nutrition Products, and Antibiotics.
Navamedic has made 1 acquisition, including Impolin.
Navamedic has 1 investor. Key investors include Reiten & Co.